Zacks Research Issues Positive Forecast for Integer Earnings

Integer Holdings Co. (NYSE:ITGR - Free Report) - Equities research analysts at Zacks Research boosted their Q1 2025 EPS estimates for shares of Integer in a research report issued to clients and investors on Thursday, December 5th. Zacks Research analyst D. Dey now expects that the medical equipment provider will post earnings of $1.31 per share for the quarter, up from their prior estimate of $1.30. The consensus estimate for Integer's current full-year earnings is $5.33 per share. Zacks Research also issued estimates for Integer's Q2 2025 earnings at $1.43 EPS, Q3 2025 earnings at $1.55 EPS, Q4 2025 earnings at $1.68 EPS, FY2025 earnings at $5.97 EPS and FY2026 earnings at $6.59 EPS.

Several other research analysts have also recently weighed in on ITGR. Benchmark upped their price target on shares of Integer from $130.00 to $140.00 and gave the stock a "buy" rating in a report on Monday, October 21st. Bank of America upped their target price on Integer from $135.00 to $145.00 and gave the stock a "buy" rating in a research note on Tuesday, October 1st. Wells Fargo & Company reiterated an "overweight" rating and set a $160.00 price target on shares of Integer in a research report on Tuesday, December 3rd. Citigroup upped their price objective on shares of Integer from $124.00 to $130.00 and gave the stock a "neutral" rating in a research report on Tuesday, October 1st. Finally, Piper Sandler reiterated an "overweight" rating and set a $140.00 target price (up from $125.00) on shares of Integer in a research report on Friday, October 25th. One analyst has rated the stock with a hold rating and eight have issued a buy rating to the company. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $142.00.

Integer Price Performance

Integer stock traded down $1.14 during midday trading on Monday, reaching $138.25. 180,877 shares of the stock were exchanged, compared to its average volume of 304,786. The company's fifty day moving average is $132.80 and its 200-day moving average is $125.29. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.09 and a current ratio of 3.28. Integer has a 52 week low of $89.65 and a 52 week high of $142.76. The firm has a market cap of $4.64 billion, a PE ratio of 42.67, a PEG ratio of 2.00 and a beta of 1.12.

Integer (NYSE:ITGR - Get Free Report) last announced its quarterly earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.07. The company had revenue of $431.42 million during the quarter, compared to analysts' expectations of $440.59 million. Integer had a return on equity of 11.63% and a net margin of 6.70%. The firm's quarterly revenue was up 8.7% compared to the same quarter last year. During the same period in the previous year, the business earned $1.27 earnings per share.

Hedge Funds Weigh In On Integer

Several institutional investors and hedge funds have recently made changes to their positions in the business. GAMMA Investing LLC grew its stake in shares of Integer by 60.9% during the second quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider's stock valued at $43,000 after buying an additional 142 shares during the last quarter. OLD National Bancorp IN purchased a new position in Integer in the 2nd quarter worth approximately $248,000. Wealth Enhancement Advisory Services LLC bought a new stake in Integer in the second quarter valued at approximately $247,000. Envestnet Portfolio Solutions Inc. lifted its position in Integer by 3.6% in the second quarter. Envestnet Portfolio Solutions Inc. now owns 5,948 shares of the medical equipment provider's stock valued at $689,000 after purchasing an additional 205 shares during the last quarter. Finally, Blue Trust Inc. boosted its stake in shares of Integer by 460.4% during the second quarter. Blue Trust Inc. now owns 5,643 shares of the medical equipment provider's stock valued at $658,000 after purchasing an additional 4,636 shares during the period. Institutional investors own 99.29% of the company's stock.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.